FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381383525> ?p ?o ?g. }

• W4381383525 abstract "Abstract Severity of atopic dermatitis (AD) itch and lesions is associated with poor quality of life. However, there is limited evidence describing the combined impact of itch and skin severity on patient outcomes in AD. This study aims to assess the independent and combined effects of itch and skin severity on patient-reported symptoms and quality-of-life outcomes. The study included adult participants (age ≥18 years) with AD enrolled in TARGET-DERM AD, an observational, longitudinal study of more than 3158 participants across 43 academic/community centers in the USA and Canada. Itch severity was assessed by the Patient-Reported Outcome Measurement Information System Itch-Severity, specifically the item evaluating ‘itch at its worst’, a 0–10 numeric rating scale. A score of 0 or 1 was interpreted as no/minimal itch. Skin severity was assessed by the validated Investigators Global Assessment of AD (vIGA-AD), with a score of 0 or 1 representing clear/almost clear skin (vIGA-AD 0/1). The association of AD symptoms representing patient-reported clear/almost clear disease [Patient-Oriented Eczema Measure (POEM) 0–2] and no impact of AD on quality of life [Dermatology Life Quality Index (DLQI) 0/1] with itch and skin severity was assessed using descriptive statistics and logistic regression models that included main and interaction effects for itch and skin severity. Among adult participants (n = 1795; 59% female; 60% non-Hispanic White; mean age 44.5 years), vIGA-AD, POEM, Worst Itch and DLQI data at enrollment were available for 95% (1702), 44% (792), 43% (783) and 43% (783) of participants, respectively. The proportion reporting POEM 0–2 and DLQI 0/1 was highest among those with no/minimal worst itch (73% POEM 0–2; 72% DLQI 0/1) and clear/almost clear skin (46% POEM 0–2; 45% DLQI 0/1), with decreasing proportions observed at greater itch and skin severity levels. Among those with both no/minimal itch and clear/almost clear skin, 87.5% (42/48) and 95.8% (46/48) reported POEM 0–2 and DLQI 0/1, respectively. Logistic regression results suggest that no/minimal itch and clear/almost clear skin are significantly associated with POEM 0–2 and DLQI 0/1, though the interaction effect was not statistically significant in despite all models assessed. Relative to those who did not have either no/minimal itch or clear/almost clear skin, the odds ratio of reporting POEM 0–2 and DLQI 0/1 was highest among those with both no/minimal itch and clear/almost clear skin (82.9 for POEM 0–2; 35.4 for DLQI 0/1), followed by no/minimal itch only (15.9 for POEM 0–2; 10.5 for DLQI 0/1) and clear/almost clear skin only (5.9 for POEM 0–2; 3.8 for DLQI 0/1). Complete or almost complete relief of itch and skin lesions is associated with greater odds of achieving ideal states in PROs (POEM and DLQI) with itch relief exhibiting a relatively higher impact than skin clearance. These results underscore the importance of assessing and documenting both itch severity and skin clearance to support shared decision-making. Moreover, clearance of both itch and skin lesions should be considered when setting treatment goals in patients with AD. Future research should include analyzing discrepant data (e.g. patients with no/minimal itch, but some skin lesions) to more precisely identify which aspect drives the patient-reported outcomes." @default.
• W4381383525 created "2023-06-21" @default.
• W4381383525 creator A5011739266 @default.
• W4381383525 creator A5016372038 @default.
• W4381383525 creator A5020095047 @default.
• W4381383525 creator A5032393407 @default.
• W4381383525 creator A5055932714 @default.
• W4381383525 creator A5064131273 @default.
• W4381383525 creator A5081439498 @default.
• W4381383525 date "2023-06-01" @default.
• W4381383525 modified "2023-09-27" @default.
• W4381383525 title "421 The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: real-world insights from TARGET-DERM AD" @default.
• W4381383525 doi "https://doi.org/10.1093/bjd/ljad162.041" @default.
• W4381383525 hasPublicationYear "2023" @default.
• W4381383525 type Work @default.
• W4381383525 citedByCount "0" @default.
• W4381383525 crossrefType "journal-article" @default.
• W4381383525 hasAuthorship W4381383525A5011739266 @default.
• W4381383525 hasAuthorship W4381383525A5016372038 @default.
• W4381383525 hasAuthorship W4381383525A5020095047 @default.
• W4381383525 hasAuthorship W4381383525A5032393407 @default.
• W4381383525 hasAuthorship W4381383525A5055932714 @default.
• W4381383525 hasAuthorship W4381383525A5064131273 @default.
• W4381383525 hasAuthorship W4381383525A5081439498 @default.
• W4381383525 hasConcept C126322002 @default.
• W4381383525 hasConcept C144024400 @default.
• W4381383525 hasConcept C151956035 @default.
• W4381383525 hasConcept C159110408 @default.
• W4381383525 hasConcept C16005928 @default.
• W4381383525 hasConcept C23131810 @default.
• W4381383525 hasConcept C2776173921 @default.
• W4381383525 hasConcept C2778329239 @default.
• W4381383525 hasConcept C2778834376 @default.
• W4381383525 hasConcept C2779134260 @default.
• W4381383525 hasConcept C2779951463 @default.
• W4381383525 hasConcept C2780699399 @default.
• W4381383525 hasConcept C30036603 @default.
• W4381383525 hasConcept C36289849 @default.
• W4381383525 hasConcept C71924100 @default.
• W4381383525 hasConceptScore W4381383525C126322002 @default.
• W4381383525 hasConceptScore W4381383525C144024400 @default.
• W4381383525 hasConceptScore W4381383525C151956035 @default.
• W4381383525 hasConceptScore W4381383525C159110408 @default.
• W4381383525 hasConceptScore W4381383525C16005928 @default.
• W4381383525 hasConceptScore W4381383525C23131810 @default.
• W4381383525 hasConceptScore W4381383525C2776173921 @default.
• W4381383525 hasConceptScore W4381383525C2778329239 @default.
• W4381383525 hasConceptScore W4381383525C2778834376 @default.
• W4381383525 hasConceptScore W4381383525C2779134260 @default.
• W4381383525 hasConceptScore W4381383525C2779951463 @default.
• W4381383525 hasConceptScore W4381383525C2780699399 @default.
• W4381383525 hasConceptScore W4381383525C30036603 @default.
• W4381383525 hasConceptScore W4381383525C36289849 @default.
• W4381383525 hasConceptScore W4381383525C71924100 @default.
• W4381383525 hasIssue "Supplement_3" @default.
• W4381383525 hasLocation W43813835251 @default.
• W4381383525 hasOpenAccess W4381383525 @default.
• W4381383525 hasPrimaryLocation W43813835251 @default.
• W4381383525 hasRelatedWork W2003620798 @default.
• W4381383525 hasRelatedWork W2109490166 @default.
• W4381383525 hasRelatedWork W2771084125 @default.
• W4381383525 hasRelatedWork W2953400705 @default.
• W4381383525 hasRelatedWork W2995377367 @default.
• W4381383525 hasRelatedWork W3158030853 @default.
• W4381383525 hasRelatedWork W3206152140 @default.
• W4381383525 hasRelatedWork W3210501554 @default.
• W4381383525 hasRelatedWork W4225272680 @default.
• W4381383525 hasRelatedWork W4318069789 @default.
• W4381383525 hasVolume "188" @default.
• W4381383525 isParatext "false" @default.
• W4381383525 isRetracted "false" @default.
• W4381383525 workType "article" @default.